The 40th Annual Meeting of Japanese Society of Oral Oncology
The 11th Educational and Training Workshop, Japanese Society of Oral Oncology
Director of Meeting, Chairman of the Educational and Training Committee Satoshi Yokoo, DMD, DMSc
(Professor, Department of Oral and Maxillofacial Surgery, and Plastic Surgery,
Gunma University Graduate School of Medicine)
I would like to extend my deep condolences for the many lives lost due to the COVID-19 pandemic since early 2020. This is a matter of heart-breaking grief for me as a healthcare professional. On this occasion, I renew my respect for the many people engaging in healthcare services and feel the urge to cope with this national crisis by uniting with people of Japan.
In the midst of this social turmoil, and despite the dim prospects for a resolution soon, we have come to hold the 40th Annual Meeting of the Japanese Society of Oral Oncology. We initially planned this meeting as a face-to-face event and made preparations accordingly, but it has evolved into a complete online meeting on the web (delivered live and on-demand) in consideration of public health and the circumstances of Gunma Prefecture and Gunma University Hospital. We regret this development as we made other preparations, expecting to meet fellow participants in Takasaki, Gunma after controlling the pandemic, but we are doing our best to make this meeting a success that is possible only on the web. We are looking forward to the registration and online participation of many people involved in the treatment of oral tumors.
The theme of the meeting is: “Oral Cancer Treatment－Evidence and Sense”. Workshops conducted by specialists for young oral oncologists that are based on the evidence concerning treatment for oral cancer but also designed to convey knacks, artisan skills, and small points of treatment not entirely explained by evidence will be highlights of the meeting. It is my hope that many topics are offered and help young oral oncologists upgrade their knowledge and skill through specialists’ suggestions.
I would like to encourage them to consider the suggestions made by many specialists in this meeting and discuss and present their thoughts in the perspective of treatment of all head and neck cancers at the 46th Annual Meeting of Japan Society for Head and Neck Cancer presided over by Dr. Tadaaki Kirita (Director: President of Japanese Society of Oral and Maxillofacial Surgeons; Professor of Department of Oral and Maxillofacial Surgery, Nara Medical University) scheduled from June 17. I further urge them to polish up their ideas and present them at the 60th Annual Meeting of Japan Society of Clinical Oncology (Director: Ken Shirabe, Professor of Department of General Surgical Science, Gunma University Graduate School of Medicine), which encompasses the entire field of cancer treatment, held in Kobe from October 20 to expand their horizons of cancer treatment and reflect on the position of clinical oral oncology.
Each day of treatment for an oral tumor is a succession of CQs. It would be much to my delight if this meeting helps the participants solve some of these CQs.